A major breakthrough in cancer research is occurring with the use of mini-antibodies to restore dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in various kinds of tumors, leading https://bookmarkedblog.com/story907178/vhh-fragments-reactivate-p53-the-promising-pathway-for-tumor-management